SEC Form 4 research
| Issuer | REGENERON PHARMACEUTICALS INC |
|---|---|
| Tickers | REGN |
| Reporting owners | 38 |
| Officers and directors | 32 |
| Last public filing | 2026-10-15 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-15 | 2026-10-14 | MURPHY ANDREW J | S | 27 | $761.36 | Not reported |
| 2026-10-15 | 2026-10-14 | MURPHY ANDREW J | S | 74 | $760.65 | Not reported |
| 2026-10-15 | 2026-10-14 | MURPHY ANDREW J | S | 14 | $759.96 | Not reported |
| 2026-10-15 | 2026-10-14 | MURPHY ANDREW J | S | 24 | $758.16 | Not reported |
| 2026-10-15 | 2026-10-14 | MURPHY ANDREW J | S | 16 | $757.68 | Not reported |
| 2026-10-15 | 2026-10-14 | MURPHY ANDREW J | S | 35 | $755.91 | Not reported |
| 2026-10-15 | 2026-10-14 | MURPHY ANDREW J | S | 6 | $753.76 | Not reported |
| 2026-10-15 | 2026-10-14 | MURPHY ANDREW J | S | 50 | $781.47 | Not reported |
| 2026-10-15 | 2026-10-14 | MURPHY ANDREW J | S | 463 | $780.63 | Not reported |
| 2026-10-15 | 2026-10-14 | MURPHY ANDREW J | S | 380 | $779.59 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.